.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
he has worked with patients under similar circumstances, but is not involved in the first lady’s case.
.
.
the news highlighted another factor in the chinese threat: regardless of the different regulatory framework, many researchers think the data they report is valid.
.
.